Nutra Biogenesis DHEA TR
Произведено Nutra Biogenesis
DHEA TR by BioGenesis is a natural supplement that provides dehydroepiandrosterone (DHEA) in a fiber-based time-release delivery system. DHEA is a metabolic precursor to other hormones and supports healthy adrenal glands and many other cells in the body.
DHEA supports healthy aging.*
May support healthy production and regulation of androgens, estrogens, cortisol*
DHEA provided in time-release delivery system
May support enhancing feelings of well-being*
May protect against cardiovascular dysfunction*
May support a healthy libido*
DHEA (or dehydroepiandrosterone) is a hormone produced by the adrenal gland and brain which serves as a precursor for all steroidal hormone production including both testosterone and estrogens. It is the bodys most abundant circulating steroid hormone, though the levels are generally higher in men than in women. Research has shown that levels peak at age 25 and markedly decline from there, with a decline of over 80% by age 70.*
DHEA TR is specifically formulated so that clinicians can prescribe a low amount of
DHEA, and increase in small increments as necessary. The fiber-based time-release
system allows the product to provide a stable amount of DHEA from which the body
can use what it needs, thus avoiding cortisol surges or fluctuations in levels of
androgens and estrogens. The time-release lasts anywhere from 6-12 hours,
depending on transit time and digestive capabilities, and this allows for a normal
circadian rhythm of both DHEA and cortisol. This should be dosed in the morning, as
this is the when the adrenal glands usually release DHEA.*
REFERENCES:
1. Baylis D, Bartlett DB, Syddall HE, Ntani G, Gale
CR, Cooper C, Lord JM, Sayer AA.
Immune-endocrine biomarkers as predictors of
frailty and mortality: a 10-year longitudinal study
in community-dwelling older people. Age (Dordr).
2012 Mar 3.
2. Creatsa M, Armeni E, Stamatelopoulos K,
Rizos D, Georgiopoulos G, Kazani M, Alexandrou
A, Dendrinos S, Augoulea A, Papamichael C,
Lambrinoudaki I. Circulating androgen levels are
associated with subclinical atherosclerosis and
arterial stiffness in healthy recently menopausal
women. Metabolism. 2012 Feb;61(2):193-201.
3. Dhatariya K, Bigelow ML, Nair KS. Effect of
dehydroepiandrosterone replacement on insulin
sensitivity and lipids in hypoadrenal women.
Diabetes. 2005 Mar;54(3):765-9.
4. Feldman HA, Johannes CB, McKinlay JB,
Longcope C. Low dehydroepiandrosterone sulfate
and heart disease in middle-aged men:
cross-sectional results from the Massachusetts
Male Aging Study. Ann Epidemiol. 1998
May;8(4):217-28.
5. Genazzani AR, Stomati M, Valentino V,
Pluchino N, Pot E, Casarosa E, Merlini S, Giannini
A, Luisi M. Effect of 1-year, low-dose DHEA
therapy on climacteric symptoms and female
sexuality. Climacteric. 2011 Dec;14(6):661-8.
6. Haden ST, Glowacki J, Hurwitz S, Rosen C,
LeBoff MS. Effects of age on serum
dehydroepiandrosterone sulfate, IGF-I, and IL-6
levels in women. Calcif Tissue Int. 2000
Jun;66(6):414-8.
7. Hartaigh BO, Loerbroks A, Thomas GN,
Engeland CG, Hollands MA, Fischer JE, Bosch
JA. Age-dependent and -independent
associations between depression, anxiety,
DHEAS, and cortisol: From the MIPH Industrial
Cohort Studies (MICS).
Psychoneuroendocrinology. 2011 Nov 30.
8. Kenny AM, Boxer RS, Kleppinger A, Brindisi J,
Feinn R, Burleson JA. Dehydroepiandrosterone
combined with exercise improves muscle strength
and physical function in frail older women. J Am
Geriatr Soc. 2010 Sep;58(9):1707-14.
9. Medina MC, Souza LC, Caperuto LC, Anh+¬ GF,
Amanso AM, Teixeira VP, Bordin S, Carpinelli AR,
Britto LR, Barbieri RL, Borella MI, Carvalho CR.
Dehydroepiandrosterone increases beta-cell
mass and improves the glucose-induced insulin
secretion by pancreatic islets from aged rats.
FEBS Lett. 2006 Jan 9;580(1):285-90.
10. Nappi RE, Albani F, Santamaria V, Tonani S,
Magri F, Martini E, Chiovato L, Polatti F. Hormonal
and psycho-relational aspects of sexual function
during menopausal transition and at early
menopause. Maturitas. 2010 Sep;67(1):78-83.
11. Osmanagaoglu MA, Okumuş B,
Osmanagaoglu T, Bozkaya H. The relationship
between serum dehydroepiandrosterone sulfate
concentration and bone mineral density, lipids,
and hormone replacement therapy in
premenopausal and postmenopausal women. J
Womens Health (Larchmt). 2004 Nov;13(9):993-9.
В наличии
Код товара: P001646
Наша цена:
₸15 390
₸15 390
Похожие товары:
Nutra Biogenesis DHEA TR
Произведено Nutra Biogenesis
В наличии
Код товара: P001646
Наша цена:
₸15 390
₸15 390
DHEA TR by BioGenesis is a natural supplement that provides dehydroepiandrosterone (DHEA) in a fiber-based time-release delivery system. DHEA is a metabolic precursor to other hormones and supports healthy adrenal glands and many other cells in the body.
DHEA supports healthy aging.*
May support healthy production and regulation of androgens, estrogens, cortisol*
DHEA provided in time-release delivery system
May support enhancing feelings of well-being*
May protect against cardiovascular dysfunction*
May support a healthy libido*
DHEA (or dehydroepiandrosterone) is a hormone produced by the adrenal gland and brain which serves as a precursor for all steroidal hormone production including both testosterone and estrogens. It is the bodys most abundant circulating steroid hormone, though the levels are generally higher in men than in women. Research has shown that levels peak at age 25 and markedly decline from there, with a decline of over 80% by age 70.*
DHEA TR is specifically formulated so that clinicians can prescribe a low amount of
DHEA, and increase in small increments as necessary. The fiber-based time-release
system allows the product to provide a stable amount of DHEA from which the body
can use what it needs, thus avoiding cortisol surges or fluctuations in levels of
androgens and estrogens. The time-release lasts anywhere from 6-12 hours,
depending on transit time and digestive capabilities, and this allows for a normal
circadian rhythm of both DHEA and cortisol. This should be dosed in the morning, as
this is the when the adrenal glands usually release DHEA.*
REFERENCES:
1. Baylis D, Bartlett DB, Syddall HE, Ntani G, Gale
CR, Cooper C, Lord JM, Sayer AA.
Immune-endocrine biomarkers as predictors of
frailty and mortality: a 10-year longitudinal study
in community-dwelling older people. Age (Dordr).
2012 Mar 3.
2. Creatsa M, Armeni E, Stamatelopoulos K,
Rizos D, Georgiopoulos G, Kazani M, Alexandrou
A, Dendrinos S, Augoulea A, Papamichael C,
Lambrinoudaki I. Circulating androgen levels are
associated with subclinical atherosclerosis and
arterial stiffness in healthy recently menopausal
women. Metabolism. 2012 Feb;61(2):193-201.
3. Dhatariya K, Bigelow ML, Nair KS. Effect of
dehydroepiandrosterone replacement on insulin
sensitivity and lipids in hypoadrenal women.
Diabetes. 2005 Mar;54(3):765-9.
4. Feldman HA, Johannes CB, McKinlay JB,
Longcope C. Low dehydroepiandrosterone sulfate
and heart disease in middle-aged men:
cross-sectional results from the Massachusetts
Male Aging Study. Ann Epidemiol. 1998
May;8(4):217-28.
5. Genazzani AR, Stomati M, Valentino V,
Pluchino N, Pot E, Casarosa E, Merlini S, Giannini
A, Luisi M. Effect of 1-year, low-dose DHEA
therapy on climacteric symptoms and female
sexuality. Climacteric. 2011 Dec;14(6):661-8.
6. Haden ST, Glowacki J, Hurwitz S, Rosen C,
LeBoff MS. Effects of age on serum
dehydroepiandrosterone sulfate, IGF-I, and IL-6
levels in women. Calcif Tissue Int. 2000
Jun;66(6):414-8.
7. Hartaigh BO, Loerbroks A, Thomas GN,
Engeland CG, Hollands MA, Fischer JE, Bosch
JA. Age-dependent and -independent
associations between depression, anxiety,
DHEAS, and cortisol: From the MIPH Industrial
Cohort Studies (MICS).
Psychoneuroendocrinology. 2011 Nov 30.
8. Kenny AM, Boxer RS, Kleppinger A, Brindisi J,
Feinn R, Burleson JA. Dehydroepiandrosterone
combined with exercise improves muscle strength
and physical function in frail older women. J Am
Geriatr Soc. 2010 Sep;58(9):1707-14.
9. Medina MC, Souza LC, Caperuto LC, Anh+¬ GF,
Amanso AM, Teixeira VP, Bordin S, Carpinelli AR,
Britto LR, Barbieri RL, Borella MI, Carvalho CR.
Dehydroepiandrosterone increases beta-cell
mass and improves the glucose-induced insulin
secretion by pancreatic islets from aged rats.
FEBS Lett. 2006 Jan 9;580(1):285-90.
10. Nappi RE, Albani F, Santamaria V, Tonani S,
Magri F, Martini E, Chiovato L, Polatti F. Hormonal
and psycho-relational aspects of sexual function
during menopausal transition and at early
menopause. Maturitas. 2010 Sep;67(1):78-83.
11. Osmanagaoglu MA, Okumuş B,
Osmanagaoglu T, Bozkaya H. The relationship
between serum dehydroepiandrosterone sulfate
concentration and bone mineral density, lipids,
and hormone replacement therapy in
premenopausal and postmenopausal women. J
Womens Health (Larchmt). 2004 Nov;13(9):993-9.